Laura Harner

Laura Harner is an Associate Director in Regulatory Affairs at Sandoz, where they bring over 20 years of expertise in global regulatory affairs across various domains, including digital health innovation and CMC. Laura previously held senior roles at Novartis, where they developed regulatory strategies and provided guidance for drug development projects. They have a strong track record of successful submissions to health authorities, including INDs and NDAs, and extensive experience liaising with the FDA. Laura earned a BS in Biology from Fordham University and an MS in Quality Assurance/Regulatory Affairs from Temple University.